Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“I’m so tired of idiots.”
Same. Particularly ones who cry daily about selling the company at 15 cents/share.
I’ll chip in if you’re short
Good point.
Unknowns will always exist.
I’m glad we agree that Elite is substantially less risky and in a much stronger position than in years past.
Hell yeah, cheers. He did seem to be on point and outlined many potential upcoming catalysts.
Agree on Oxy. I hope we are first to file and able to launch it relatively soon after approval.
Shouldn’t you be happy about the solid call and the solid quarter results? Lol.
I think you’re conflating missed goals like Nasdaq and nefarious intent re: hostile takeover of the company. I’m saying regardless of what you believe his intent actually is, the logic simply doesn’t follow. If he wanted to take it private, he could’ve done so long ago and wouldn’t have spent the time, money, and effort to make the company more valuable. Just doesn’t make sense.
“The Company also submitted partial ANDA for pain management for FDA review. The partial application contained the recently concluded insufflation study. Elite received correspondence from FDA requesting certain information.
**The information has been gathered and the response will be out to FDA this week.** **This is one of the three needle mover products that I spoke of six weeks ago.** Elite has another product that is undergoing a pivotal DE clinical trial. If we pass then we expect to file this ANDA this year. **Just to make sure that everybody understands me, two of the three needle mover ANDAs as I spoke of will be filed this year.”**
So call it Friday, 8/18 to be safe? Should expect the Oxy generic announcement from Elite after hearing back from the FDA (45-60 days), puts it roughly somewhere between 10/2/23 - 10/17/23, assuming no more data requests.
2 of 3 needle mover filings to be completed by EOY. Nasrat also confirmed that the needle movers are all in either pain management or stimulant categories and 2 of the 3 may be bigger than our Adderralls.
“But all evidence right now shows that these products will be as big, if not bigger than Adderall IR and ER at least two of the three.”
Lmao. He picked it apart and I’m glad, that’s why I sent the question. He said essentially what I already said here before - why spend so much time and energy growing the company when you could do the opposite, sabotage it and take it over cheap? The logic just doesn’t follow.
Also good that he acknowledged buybacks are “on the table”, just undoubtedly down the road a bit.
Sure chief, see ya tomorrow.
“I never doubted their effort and results.”
LOL. Little historical revisionism there, eh??
Hahaha called in to reinforce?? That’s how you know today went well.
You’re welcome.
You’re welcome. Sounds like a new King dethroned the old one.
He said with the caveat of when the company can afford it. They voted to do it last year but hadn’t been able to yet.
You’re welcome for me submitting a lot of those Q’s.
Satisfied, @IB??? Didn’t his answer essentially mimic what I already posted awhile back?
If he wanted to take us over, he would’ve done it already. They are clearly making plans to pay salaries all cash and buybacks are on the table for the future. Ya welcome for the questions I sent, just for you.
My long question as well lmao
This one was for IB ;)
That’s one of ya boy’s questions right there. ;)
I wish. That’s awesome, congrats. Stand to make bank if this plays out like we expect!
It was the threshold for Epic’s buyout. Of course each situation will vary, depending on the target co and the acquirer.
My man. Cheers.
Thought it looked familiar too, can’t place it right now though.
Edit - ah yes, the Lodrane days. Blast from the past.
They never PR’d the partial application from recent months.
As far as the Q filing and subsequent events, are they responsible for including every business event until EOB the day of filing the Q? What’s the cutoff?
Fake financials? That’s original at least. LOL.
I was typing that before I even saw your post so how did I copy??
I read the filing. There is other language, for example, that basically says the LPC agreement from 2020 expires on August 1, 2023.
See what I mean? That date already passed but it’s included like it’s future tense. They could’ve still submitted the final Oxy insufflation data but that could’ve occurred after the Q was finalized.
Now you’re gettin it!!
Right. But I’m saying they could’ve still submitted the final data on 8/1 because this Q filing does not cover the 8/1 time period, correct?
So every CEO who undershoots revenues is misleading investors? Lol
Desperate, even for you folks
Couldn’t it still have been filed on 8/1? Isn’t that beyond the scope of this report?
Womp womp for our boiler room friends
Show me on the doll where ELTP hurt you.
Several of y’all have an infatuation with trashing this stock and company. It’s really weird.
Yeah I thought he meant some of the bigger candidates we have in the last clinical stages but not yet filed. Hopefully tomorrow’s call sheds more light.
I also asked about Oxy exclusivity details, who if anyone do we have to wait on before launching, once approved.
I was under the impression that none of the products considered needle movers have been filed yet. I would agree that those two pending approval don’t sound massively impactful. Positive, but not game changing.
I figured Oxy was likely one of the big ones, with a possible Concerta and whatever else.
I asked specifically about market sizes / IMS numbers on the “needle mover” products and in which category they expect the biggest opportunity from (opioid, stimulant, etc.)
Also specifically asked if they have had further conversations with FDA/DEA and if so, do they anticipate us getting additional quota late this year or next.
Sent to Dianne already, prior to whatever the cutoff was. We’ll see!
Lol see you tomorrow